Join
Live feed
·
PRReleasevia Quantisnow
Palisade Bio Inc. logo

Palisade Bio (Nasdaq: PALI) Announces Analysis Demonstrating LB1148 Reduced the Extent and Severity of Post-Surgical Intraabdominal Adhesions by 93%

ByQuantisnow·Wall Street's wire, on your screen.
PALI· Palisade Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PALI (Palisade Bio Inc.) and more on Quantisnow.